OBJECTIVE: Disturbed sleep and depression are potential risk factors for pregnancy complications. Both conditions are known to dysregulate biological pathways responsible for maintaining homeostatic balance and pregnancy health. Depression during pregnancy is associated with poor sleep. Thus, we explored whether disturbed sleep was associated with inflammatory cytokines and risk for adverse pregnancy outcomes, as well as whether depression augmented the sleep-cytokine relationship, thereby additively contributing to risk for adverse outcomes. METHODS: Interview-assessed sleep and plasma cytokine concentrations were evaluated in a cohort of depressed and nondepressed pregnant women (n = 168) at 20 and 30 weeks' gestation. Outcomes evaluated included preterm birth, birth weight, and peripartum events. RESULTS: Among depressed women, short sleep duration (<7 hours) was associated with higher interleukin (IL)-8 across time (β = 0.506, p = .001), poor sleep efficiency (<85%) was associated with higher IL-6 (β = 0.205, p = .006), and daytime naps were associated with higher tumor necrosis factor α (β = 0.105, p = .024). Aspects of poor sleep were associated with having a lower weight baby (p values <.053). Among depressed women, interferon-γ increased risk for preterm birth (odds ratio = 1.175, p = .032). Trends for IL-6 and higher birth weight (β = 105.2, p = .085), interferon-γ and lower birth weight (β = -19.92, p < .069), and increased IL-8 and babies weighing less than 4000 grams (odds ratio = 0.72, p < .083) were observed. CONCLUSIONS: Although speculative, disturbed sleep may disrupt normal immune processes and contribute to adverse pregnancy outcomes. Exploratory analyses indicate that depression modifies these relationships.
OBJECTIVE: Disturbed sleep and depression are potential risk factors for pregnancy complications. Both conditions are known to dysregulate biological pathways responsible for maintaining homeostatic balance and pregnancy health. Depression during pregnancy is associated with poor sleep. Thus, we explored whether disturbed sleep was associated with inflammatory cytokines and risk for adverse pregnancy outcomes, as well as whether depression augmented the sleep-cytokine relationship, thereby additively contributing to risk for adverse outcomes. METHODS: Interview-assessed sleep and plasma cytokine concentrations were evaluated in a cohort of depressed and nondepressed pregnant women (n = 168) at 20 and 30 weeks' gestation. Outcomes evaluated included preterm birth, birth weight, and peripartum events. RESULTS: Among depressedwomen, short sleep duration (<7 hours) was associated with higher interleukin (IL)-8 across time (β = 0.506, p = .001), poor sleep efficiency (<85%) was associated with higher IL-6 (β = 0.205, p = .006), and daytime naps were associated with higher tumor necrosis factor α (β = 0.105, p = .024). Aspects of poor sleep were associated with having a lower weight baby (p values <.053). Among depressedwomen, interferon-γ increased risk for preterm birth (odds ratio = 1.175, p = .032). Trends for IL-6 and higher birth weight (β = 105.2, p = .085), interferon-γ and lower birth weight (β = -19.92, p < .069), and increased IL-8 and babies weighing less than 4000 grams (odds ratio = 0.72, p < .083) were observed. CONCLUSIONS: Although speculative, disturbed sleep may disrupt normal immune processes and contribute to adverse pregnancy outcomes. Exploratory analyses indicate that depression modifies these relationships.
Authors: Kate M Edwards; Lianne M Tomfohr; Paul J Mills; Jos A Bosch; Sonia Ancoli-Israel; Jose S Loredo; Joel Dimsdale Journal: Sleep Date: 2011-02-01 Impact factor: 5.849
Authors: Michele L Okun; Charles F Reynolds; Daniel J Buysse; Timothy H Monk; Sati Mazumdar; Amy Begley; Martica Hall Journal: Psychosom Med Date: 2010-11-19 Impact factor: 4.312
Authors: Michele L Okun; Kerith Kiewra; James F Luther; Stephen R Wisniewski; Katherine L Wisner Journal: Depress Anxiety Date: 2011-05-23 Impact factor: 6.505
Authors: Philip C Calder; Namanjeet Ahluwalia; Fred Brouns; Timo Buetler; Karine Clement; Karen Cunningham; Katherine Esposito; Lena S Jönsson; Hubert Kolb; Mirian Lansink; Ascension Marcos; Andrew Margioris; Nathan Matusheski; Herve Nordmann; John O'Brien; Giuseppe Pugliese; Salwa Rizkalla; Casper Schalkwijk; Jaakko Tuomilehto; Julia Wärnberg; Bernhard Watzl; Brigitte M Winklhofer-Roob Journal: Br J Nutr Date: 2011-12 Impact factor: 3.718
Authors: Michele L Okun; Jim Luther; Aric A Prather; James M Perel; Stephen Wisniewski; Katherine L Wisner Journal: J Affect Disord Date: 2010-08-12 Impact factor: 4.839
Authors: Lauren Clevenger; Andrew Schrepf; Desire Christensen; Koen DeGeest; David Bender; Amina Ahmed; Michael J Goodheart; Frank Penedo; David M Lubaroff; Anil K Sood; Susan K Lutgendorf Journal: Brain Behav Immun Date: 2012-04-21 Impact factor: 7.217
Authors: Francieli S Ruiz; Monica L Andersen; Raquel C S Martins; Adriano Zager; José D Lopes; Sergio Tufik Journal: Innate Immun Date: 2010-11-18 Impact factor: 2.680
Authors: Kristen C Stone; Amy L Salisbury; Cynthia L Miller-Loncar; Jennifer A Mattera; Cynthia L Battle; Dawn M Johnsen; Kevin E O'Grady Journal: Arch Womens Ment Health Date: 2017-05-09 Impact factor: 3.633
Authors: Bingqian Zhu; Ulf G Bronas; David W Carley; Kathryn Lee; Alana Steffen; Mary C Kapella; Bilgay Izci-Balserak Journal: Ann N Y Acad Sci Date: 2020-05-28 Impact factor: 5.691
Authors: Dorota Wołyńczyk-Gmaj; Anna Różańska-Walędziak; Simon Ziemka; Marcin Ufnal; Aneta Brzezicka; Bartłomiej Gmaj; Piotr Januszko; Sylwia Fudalej; Krzysztof Czajkowski; Marcin Wojnar Journal: J Clin Sleep Med Date: 2017-10-15 Impact factor: 4.062